rs144347039
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_019892.6(INPP5E):c.1159+30T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0209 in 1,609,640 control chromosomes in the GnomAD database, including 501 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 40 hom., cov: 34)
Exomes 𝑓: 0.021 ( 461 hom. )
Consequence
INPP5E
NM_019892.6 intron
NM_019892.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.57
Publications
2 publications found
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
INPP5E Gene-Disease associations (from GenCC):
- Joubert syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- MORM syndromeInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, ClinGen, Orphanet
- COACH syndrome 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with ocular defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 9-136433125-A-T is Benign according to our data. Variant chr9-136433125-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0556 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INPP5E | NM_019892.6 | c.1159+30T>A | intron_variant | Intron 4 of 9 | ENST00000371712.4 | NP_063945.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0169 AC: 2569AN: 151564Hom.: 40 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
2569
AN:
151564
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0185 AC: 4537AN: 245098 AF XY: 0.0190 show subpopulations
GnomAD2 exomes
AF:
AC:
4537
AN:
245098
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0213 AC: 31058AN: 1457958Hom.: 461 Cov.: 54 AF XY: 0.0213 AC XY: 15474AN XY: 725400 show subpopulations
GnomAD4 exome
AF:
AC:
31058
AN:
1457958
Hom.:
Cov.:
54
AF XY:
AC XY:
15474
AN XY:
725400
show subpopulations
African (AFR)
AF:
AC:
248
AN:
33378
American (AMR)
AF:
AC:
797
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
AC:
2091
AN:
26114
East Asian (EAS)
AF:
AC:
9
AN:
39662
South Asian (SAS)
AF:
AC:
709
AN:
86250
European-Finnish (FIN)
AF:
AC:
189
AN:
50128
Middle Eastern (MID)
AF:
AC:
351
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
25173
AN:
1111664
Other (OTH)
AF:
AC:
1491
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
1613
3226
4839
6452
8065
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
968
1936
2904
3872
4840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0169 AC: 2567AN: 151682Hom.: 40 Cov.: 34 AF XY: 0.0167 AC XY: 1237AN XY: 74166 show subpopulations
GnomAD4 genome
AF:
AC:
2567
AN:
151682
Hom.:
Cov.:
34
AF XY:
AC XY:
1237
AN XY:
74166
show subpopulations
African (AFR)
AF:
AC:
293
AN:
41150
American (AMR)
AF:
AC:
373
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
AC:
281
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5150
South Asian (SAS)
AF:
AC:
33
AN:
4820
European-Finnish (FIN)
AF:
AC:
31
AN:
10610
Middle Eastern (MID)
AF:
AC:
13
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1459
AN:
67924
Other (OTH)
AF:
AC:
58
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
122
243
365
486
608
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Jul 05, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.